Our recent work identified hCAP18/LL-37 as a tumor-promoting factor that stimulates HCC proliferation and growth, thereby attenuating the anticancer efficacy of 1,25(OH)2D3 in mouse models (20). Here, CAMP is linked to hepatocellular carcinoma.